ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
119.137,86
0,00%
S&P 500
5.473,23
0,00%
US Dollar vs BRL
5,4233
-0,04%
Bitcoin
64.896,08
-2,40%
Brent Oil
83,825
-0,09%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NYSE
  6. Meridian Gold (MDG)

  7. Meridian Gold (MDG) Notícias

MDG

Meridian Gold (MDG)

Meridian Gold
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NYSE:MDG
DataHoraFonteTítuloCódigoCompanhia
27/01/201406:23GlobeNewswireMedigene acquires Trianta ImmunotherapiesNYSE:MDGMeridian Gold
27/01/201406:22GlobeNewswireMedigene übernimmt Trianta ImmunotherapiesNYSE:MDGMeridian Gold
18/12/201304:30GlobeNewswireMedigene's drug Veregen® launched in Norway and SwedenNYSE:MDGMeridian Gold
18/12/201304:30GlobeNewswireMedigenes Medikament Veregen® kommt in Norwegen und Schweden auf den MarktNYSE:MDGMeridian Gold
13/12/201304:30GlobeNewswireMedigene Granted Additional Patent for RhuDex® for the Treatment of Autoimmune DiseasesNYSE:MDGMeridian Gold
13/12/201304:30GlobeNewswireMedigene erhält weiteres europäisches Patent für Autoimmun-Medikamentenkandidaten RhuDex®NYSE:MDGMeridian Gold
11/12/201304:30GlobeNewswireMedigene announces Veregen® to be launched in the Czech Republic, Poland, Hungary, and SlovakiaNYSE:MDGMeridian Gold
11/12/201304:30GlobeNewswireMedigene kündigt Markteinführung von Veregen® in Tschechien, Polen, Ungarn und der Slowakei anNYSE:MDGMeridian Gold
05/12/201304:31GlobeNewswireTaurus becomes new marketing partner for Medigene's drug Veregen® in GermanyNYSE:MDGMeridian Gold
05/12/201304:30GlobeNewswireTaurus wird neuer Partner für Medigenes Medikament Veregen® in DeutschlandNYSE:MDGMeridian Gold
08/11/201304:30GlobeNewswireMedigene reports financial results for the first nine months of 2013NYSE:MDGMeridian Gold
08/11/201304:30GlobeNewswireMedigene veröffentlicht 9-Monats-Finanzbericht 2013NYSE:MDGMeridian Gold
01/10/201302:30GlobeNewswireMedigene announces market launch of Veregen® in TaiwanNYSE:MDGMeridian Gold
01/10/201302:30GlobeNewswireMedigene gibt Markteinführung von Veregen® in Taiwan bekanntNYSE:MDGMeridian Gold
10/09/201302:30GlobeNewswireMedigene's Drug Veregen® receives market approval in CanadaNYSE:MDGMeridian Gold
10/09/201302:30GlobeNewswireMedigenes Medikament Veregen® erhält Zulassung für KanadaNYSE:MDGMeridian Gold
21/08/201302:31GlobeNewswireMedigene to implement 4:1 share capital reduction effective 3 September 2013NYSE:MDGMeridian Gold
21/08/201302:30GlobeNewswireMedigene vollzieht angekündigte 4:1 Kapitalherabsetzung mit Wirkung zum 3. September 2013NYSE:MDGMeridian Gold
09/08/201302:30GlobeNewswireMedigene veröffentlicht 6-Monats-Finanzbericht 2013NYSE:MDGMeridian Gold
09/08/201302:30GlobeNewswireMedigene reports financial results for the first 6 months of 2013NYSE:MDGMeridian Gold
06/08/201302:31GlobeNewswireMedigene and Difa Cooper enter into agreement for the commercialization of Veregen® in ItalyNYSE:MDGMeridian Gold
06/08/201302:30GlobeNewswireMedigene und Difa Cooper vereinbaren Partnerschaft zur Vermarktung von Veregen® in ItalienNYSE:MDGMeridian Gold
29/07/201302:30GlobeNewswireMedigene AG: Markteinführung von Veregen® in Niederlanden gestartetNYSE:MDGMeridian Gold
29/07/201302:30GlobeNewswireMedigene AG: Market launch of Veregen® in the Netherlands startedNYSE:MDGMeridian Gold
17/07/201310:58GlobeNewswireMedigene Reports Outcome of Annual General MeetingNYSE:MDGMeridian Gold
17/07/201310:58GlobeNewswireMedigene berichtet über Ergebnisse der HauptversammlungNYSE:MDGMeridian Gold
05/06/201303:03GlobeNewswireMedigene plant Herabsetzung des Grundkapitals sowie Verkleinerung und Neuwahl des AufsichtsratsNYSE:MDGMeridian Gold
05/06/201303:03GlobeNewswireMedigene announces capital reduction and nomination of new members to a reduced Supervisory BoardNYSE:MDGMeridian Gold
04/06/201303:00GlobeNewswireMedigene's drug Veregen® receives market authorization notification in TaiwanNYSE:MDGMeridian Gold
04/06/201303:00GlobeNewswireMedigenes Medikament Veregen® erhält Zulassung für TaiwanNYSE:MDGMeridian Gold
 Apresentando as notícias mais relevantes sobre:NYSE:MDG

Seu Histórico Recente

USOTC
SPPSY
Sopra Steria (PK)
LSE
78EC
Euro.bk.40
BIT
F35099
Vontobel Financial Produ...
BIT
F19712
Vontobel Financial Produ...
BIT
UC3JSV
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados